Expression pattern of neural synaptic plasticity marker-Arc in different brain regions induced by conditioned drug withdrawal from acute morphine-dependent rats

Acta Pharmacologica Sinica

Volumn 30, Issue 3, 2009, Pages 282-290

  Li, Mu ^a   Hou, Yuan Yuan ^a   Lu, Bin ^a   Chen, Jie ^a   Chi, Zhi Qiang ^a   Liu, Jing Gen ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Amygdala; Arc; Conditioned place aversion; Negative reinforcing effects; Prefrontal cortex; Rats; Striatum; Withdrawal

Indexed keywords

ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; BIOLOGICAL MARKER; MESSENGER RNA; MORPHINE; NALOXONE; ACTIVITY REGULATED CYTOSKELETAL-ASSOCIATED PROTEIN; CYTOSKELETON PROTEIN; NARCOTIC ANTAGONIST; NERVE PROTEIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CONDITIONING; CONTROLLED STUDY; CORPUS STRIATUM; DENDRITE; DRUG WITHDRAWAL; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL PLASTICITY; NONHUMAN; PLACE PREFERENCE; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REINFORCEMENT; SENSORY CORTEX; ANIMAL; ANIMAL BEHAVIOR; BRAIN; DRUG EFFECT; GENETICS; HISTOLOGY; HUMAN; METABOLISM; MORPHINE ADDICTION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CONDITIONING (PSYCHOLOGY); CYTOSKELETAL PROTEINS; HUMANS; MALE; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 64849083319     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2009.10     Document Type: Article

References (47)

1. Higgins GA, Sellers EM. Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs. Pharmacol Biochem Behav 1994; 48: 1-8.
2. Koob GF. Neurobiology of addiction. Toward the development of newtherapies. Ann N Y Acad Sci 2000; 909: 170-85.
3. Stinus L, Le Moal M, Koob GF. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 1990; 37: 767-73.
4. Azar MR, Jones BC, Schulteis G. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal. Psychopharmacology 2003; 170: 42-50.
5. Parker LA, Cyr JA, Santi AN, Burton PD. The aversive properties of acute morphine dependence persist 48 h after a single exposure to morphine: evaluation by taste and place conditioning. Pharmacol Biochem Behav 2002; 72: 87-92.
6. White DA, Hwang ML, Holtzman SG. Naltrexone-induced conditioned place aversion following a single dose of morphine in the rat. Pharmacol Biochem Behav 2005; 81: 451-8.
7. Jin C, Araki H, Hagata M, Suemaru K, Shibata K, Kawaski H, et al. Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure. Psycho-pharmacology 2004; 175:428-35.
8. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006; 29: 565-98.
9. Kuipers SD, Bramham CR. Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Curr Opin Drug Discov Devel 2006; 9: 580-6.
10. Abraham WC, Mason SE, Demmer J, Williams JM, Richardson CL, Tate WP, et al. Correlations between immediate early gene induction and the persistence of long-term potentiation. Neuroscience 1993; 56: 717-27.
11. Worley PF, Bhat RV, Baraban JM, Erickson CA, McNaughton BL, Barnes CA. Thresholds for synaptic activation of transcription factors in hippocampus: correlation with long-term enhancement. J Neurosci 1993; 13: 4776-86.
12. Hess US, Lynch G, Gall CM. Regional patterns of c-fos mRNA expression in rat hippocampus following exploration of a novel environment versus performance of a well-learned discrimination. J Neurosci 1995; 15: 7796-809.
13. Nagahara AH, Handa RJ. Fetal alcohol exposure alters the induction of immediate early gene mRNA in the rat prefrontal cortex after an alternation task. Alcohol Clin Exp Res 1995; 19: 1389-97.
14. Vann SD, Brown MW, ErichsenJT, AggletonJP. Using fos imaging in the rat to reveal the anatomical extent of the disruptive effects of fornix lesions. J Neurosci 2000; 20: 8144-52.
15. Seeds NW, Williams BL, Bickford PC. Tissue plasminogen activator induction in Purkinje neurons after cerebellar motor learning. Science 1995; 270: 1992-4.
16. Link W, Konietzko U, Kauselmann G, Krug M, Schwanke B, Frey U, et al. Somatodendritic expression of an immediate early gene is regulated by synaptic activity. Proc Natl Acad Sci USA 1995; 92: 5734-8.
17. Tzingounis AV, Nicoll RA. Arc/Arg3.1: linking gene expression to synaptic plasticity and memory. Neuron 2006; 52: 403-7.
18. Lyford GL, Yamagata K, Kaufmann WE, Barnes CA, Sanders LK, Copeland NG, et al. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 1995; 14: 433-45.
19. Steward O, Wallace CS, Lyford GL, Worley PF. Synaptic activation causes the mRNA for the IEG Arc to localize selectively near activated postsynaptic sites on dendrites. Neuron 1998; 21: 741-51.
20. Mucha RF, Walker MJ. Aversive property of opioid receptor blockade in drug-naive mice. Psychopharmacology (Berl) 1987; 93: 483-8.
21. Guzowski JF, Setlow B, Wagner EK, McGaugh JL. Experience-dependent gene expression in the rat hippocampus after spatial learning: a comparison of the immediate-early genes Arc, c-fos, and zif268. J Neurosci 2001; 21: 5089-98.
22. Kelly MP, Deadwyler SA. Experience-dependent regulation of the immediate-early gene arc differs across brain regions. J Neurosci 2003; 23: 6443-51.
23. McIntyre CK, Miyashita T, Setlow B, Marjon KD, Steward O, Guzowski JF, et al. Memory-influencing intra-basolateral amygdala drug infusions modulate expression of Arc protein in the hippocampus. Proc Natl Acad Sci USA 2005; 102: 10718-23.
24. Hutcheson DM, Everitt BJ, Robbins TW, Dickinson A. The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nat Neurosci 2001; 4: 943-7.
25. Rodriguez de Fonseca F, Navarro M. Role of the limbic system in dependence on drugs. Ann Med 1998; 30: 397-405.
26. Koob GF. Drug addiction: the yin and yang of hedonic homeo-stasis. Neuron 1996; 16: 893-6.
27. Bechara A, Nader K, van der Kooy D. A two-separate-motivational-systems hypothesis of opioid addiction. Pharmacol Bio-chem Behav 1998; 59: 1-17.
28. Schaefer GJ, Michael RP. Changes in response rates and reinforcement thresholds for intracranial self-stimulation during morphine withdrawal. Pharmacol BiochemBehav 1986; 25: 1263-9.
29. Thomas KL, Arroyo M, Everitt BJ. Induction of the learning and plasticity-associated gene Zif268 following exposure to a discrete cocaine-associated stimulus. Eur J Neurosci 2003; 17: 1964-72.
30. DalleyJW, Cardinal RN, Robbind TW. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 2004; 28: 771-84.
31. JentschJD, Taylor JR. Impulsive resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology 1999; 146: 373-90.
32. Cardinal RN, Parkinson JA, Hall J, Everitt BJ. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 2002; 26: 321-52.
33. Ridderinkhof KR, Van den Wildenberg WP, Segalowitz SJ, Carter CS. Neurocognitive mechanisms of cognitive control: the role of prefrontal cortex in action selection, response inhibition, performance monitoring, and reward-based learning. Brain Cogn 2004; 56: 129-40.
34. Floresco SB, Tse MT. Dopaminergic regulation of inhibitory and excitatory transmission in the basolateral amygdale-prefrontal cortical pathway. J Neurosci 2007; 27: 2045-57.
35. Ridderinkhof KR, Ullsperger M, Crone EA, Nieuwenhuis S. The role of the medial frontal cortex in cognitive control. Science 2004; 306: 443-7.
36. Voorn P, Vanderschuren LJMJ, Groenewegen HJ, Robbins TW, Pennartz CMA. Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci 2004; 27: 468-74.
37. WickensJR, Reynolds JN, Hyland BI. Neural mechanisms of reward-related motor learning. Curr Opin Neurobiol 2003; 13: 685-90.
38. Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM. It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci 2003 ; 26: 184-92.
39. Alheid GF, Beltramino CA, De Olmos JS, Forbes MS, Swanson DJ, Heimer L. The neuronal organization of the supracapsular part of the stria terminalis in the rat: the dorsal component of the extended amygdala. Neuroscience 1998; 84: 967-96.
40. Gallagher M, Chiba AA. The amygdala and emotion. Curr Opin Neurobiol 1996; 6: 221-7.
41. Koob GF. The role of the striatopallidal and extended amygdala systems in drug addiction. Ann N Y Acad Sci 1999; 877: 445-60.
42. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology2001; 24: 97-129.
43. Heinrichs SC, Menzaghi F, Schulteis G, Koob GF, Stinus L. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol 1995; 6: 74-80.
44. DelfsJM, Zhu Y, DruhanJP, Aston-Jones G. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 2000; 403: 430-4.
45. Frenois F, Cador M, Caille S, Stinus L, Le Moine C. Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 2002; 16: 1377-89.
46. Frenois F, Stinus L, Di Blasi F, Cador M, Le Moine CA. Specific limbic circuit underlies opiate withdrawal memories. J Neurosci 2005; 25: 1366-74.
47. DayJJ, Carelli RM. The nucleus accumbens and Pavlovian reward learning. Neuroscientist 2007; 13: 148-59.